November 21, 2017 Non Regulatory InDex Pharmaceuticals presenterar på Redeye Life Science Seminar 24 november 2017 Read more
November 16, 2017 Non Regulatory InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee and financial reporting dates for 2018 Read more
November 16, 2017 Non Regulatory InDex Pharmaceuticals Holding AB (publ) offentliggör valberedning och datum för finansiell rapportering 2018 Read more
October 26, 2017 Non Regulatory InDex Pharmaceuticals will participate in the United European Gastroenterology Week (UEGW) Read more
October 26, 2017 Non Regulatory InDex Pharmaceuticals deltar på United European Gastroenterology Week (UEGW) Read more
August 9, 2017 Non Regulatory InDex Pharmaceuticals receives orphan-drug designation for pediatric ulcerative colitis in the US Read more
August 9, 2017 Non Regulatory InDex Pharmaceuticals får särläkemedelsstatus för pediatrisk ulcerös kolit beviljad i USA Read more
May 5, 2017 Non Regulatory InDex Pharmaceuticals will participate in the Digestive Disease Week (DDW) Read more
March 22, 2017 Non Regulatory InDex Pharmaceuticals concludes well attended Investigators’ Meeting for the phase IIb study CONDUCT Read more
March 22, 2017 Non Regulatory InDex Pharmaceuticals har genomfört ett välbesökt prövarmöte för fas IIb-studien CONDUCT Read more
March 20, 2017 Non Regulatory InDex Pharmaceuticals presenterar på Stockholm Corporate Finance Life Science Seminarium Read more
January 23, 2017 Non Regulatory InDex Pharmaceuticals will participate in the European Crohn’s and Colitis Organisation (ECCO) Congress Read more
January 23, 2017 Non Regulatory InDex Pharmaceuticals deltar på europeiska Crohns- och kolit-organisationens (ECCO) kongress Read more